Skip to main content
. 2020 Aug 28;50(5):822–826. doi: 10.1016/j.semarthrit.2020.08.002

Fig. 2.

Fig. 2

Trends in Total Medicare Spending on biologic DMARDs used for RA between 2012–2017.